| Deciphering the Molecular Association of Human CRIP1a with an Agonist-Bound Cannabinoid Receptor 1. | Deciphering the Molecular Association of Human CRIP1a with an Agonist-Bound Cannabinoid Receptor 1.
Petgrave M, Ramgoolam SD, Ganesan A. | 01/29/2024 |
| DNA Methylation of Cannabinoid Receptor Interacting Protein 1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin-Dependent Pyruvate Kinase M2 Ubiquitination. | DNA Methylation of Cannabinoid Receptor Interacting Protein 1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin-Dependent Pyruvate Kinase M2 Ubiquitination.
Chen D, Wu H, Feng X, Chen Y, Lv Z, Kota VG, Chen J, Wu W, Lu Y, Liu H, Zhang Y, Zheng S, Wu J. | 01/8/2022 |
| Cannabinoid Receptor Type 1 Regulates Drug Reward Behavior via Glutamate Decarboxylase 67 Transcription. | Cannabinoid Receptor Type 1 Regulates Drug Reward Behavior via Glutamate Decarboxylase 67 Transcription.
Gu SM, Seo S, Park D, Kim S, Lamichhane S, Han KM, Kim YH, Lee S, Hong JT, Cha HJ, Yun J., Free PMC Article | 10/30/2021 |
| Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease. | Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease.
Oliver EE, Hughes EK, Puckett MK, Chen R, Lowther WT, Howlett AC., Free PMC Article | 09/11/2021 |
| A rare genomic duplication in 2p14 underlies autosomal dominant hearing loss DFNA58. | A rare genomic duplication in 2p14 underlies autosomal dominant hearing loss DFNA58.
Lezirovitz K, Vieira-Silva GA, Batissoco AC, Levy D, Kitajima JP, Trouillet A, Ouyang E, Zebarjadi N, Sampaio-Silva J, Pedroso-Campos V, Nascimento LR, Sonoda CY, Borges VM, Vasconcelos LG, Beck RMO, Grasel SS, Jagger DJ, Grillet N, Bento RF, Mingroni-Netto RC, Oiticica J., Free PMC Article | 08/14/2021 |
| Tat-Cannabinoid Receptor Interacting Protein Reduces Ischemia-Induced Neuronal Damage and Its Possible Relationship with 14-3-3eta. | Tat-Cannabinoid Receptor Interacting Protein Reduces Ischemia-Induced Neuronal Damage and Its Possible Relationship with 14-3-3η.
Kwon HJ, Kim DS, Kim W, Jung HY, Yu YH, Ju YI, Park DK, Hwang IK, Kim DW, Yoo DY., Free PMC Article | 03/13/2021 |
| Through investigations of the function and structure of CRIP1a, new pharmacotherapies based upon the CRIP-CB1 receptor interaction can be designed to treat diseases such as epilepsy, motor dysfunctions and schizophrenia | Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure.
Booth WT, Walker NB, Lowther WT, Howlett AC., Free PMC Article | 02/22/2020 |
| The Arg82 and Cys126 of CRIP1b are involved in the majority of hydrogen bond interactions with the CB1 receptor and are possible key residues required for interactions between the CB1 receptor and CRIP1b | In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor.
Singh P, Ganjiwale A, Howlett AC, Cowsik SM., Free PMC Article | 07/28/2018 |
| CNRIP1 and RUNX3 as potential DNA methylation biomarkers for CRC diagnosis and treatment | Screening of exon methylation biomarkers for colorectal cancer via LC-MS/MS strategy.
Huang Q, Yang Q, Mo M, Ye X, Zhang J, Zhang L, Chen B, Li J, Cai C. | 03/10/2018 |
| CRIP1a can compete with beta-arrestins for interaction with C-terminal CB1R domains that could affect agonist-driven, beta-arrestin-mediated internalization of the CB1R. | Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites.
Blume LC, Patten T, Eldeeb K, Leone-Kabler S, Ilyasov AA, Keegan BM, O'Neal JE, Bass CE, Hantgan RR, Lowther WT, Selley DE, Howlett AL., Free PMC Article | 05/13/2017 |
| Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator) | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR., Free PMC Article | 06/30/2010 |